Flashpoint Therapeutics
PrivateLast Round
Seed
Oct 25, 2023
Est. Valuation
$35M
Total Funding Raised
$20M
Company Overview
Flashpoint Therapeutics is a biotechnology company that develops precision-engineered structural nanomedicines for cancer and other diseases by co-delivering RNA, DNA, and peptide cargo to specific cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Flashpoint Therapeutics Comparables
Compare Flashpoint Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DNA Nanobots | 86% | |
| SNC Therapeutics, Inc. | 86% | |
| Entos Pharmaceuticals | 85% |
Flashpoint Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 25, 2023 | ||||
| Seed | Oct 25, 2023 | ||||
| Pre Seed | Jan 30, 2023 |
Flashpoint Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beta Lab | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2025
Barry Labinger appointed as new Chief Executive Officer.
Flashpoint Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Flashpoint Therapeutics's valuation, stock price, and market status.
Is Flashpoint Therapeutics a public or private company?
Flashpoint Therapeutics is a private company.
What is the current stock price of Flashpoint Therapeutics?
Flashpoint Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Flashpoint Therapeutics worth (valuation)?
Flashpoint Therapeutics's valuation is estimated at $35.0M based on funding round data.
Can I buy Flashpoint Therapeutics stock?
Flashpoint Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Flashpoint Therapeutics's last funding round?
Flashpoint Therapeutics's most recent funding round was Seed on October 25, 2023.
Who are the main investors in Flashpoint Therapeutics?
Key investors in Flashpoint Therapeutics include Beta Lab.
Will Flashpoint Therapeutics IPO soon?
No public IPO plans have been announced for Flashpoint Therapeutics.
How can I track Flashpoint Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Flashpoint Therapeutics's secondary market activity and sign up for updates.